martes, 7 de enero de 2014

Erez Vigodman eres el CEO que te vas para TEVA?

According to several reports, Teva is expected to name current board member Erez Vigodman as its new CEO. Citi Group analyst Liav Abraham suggested that the appointment is likely to be announced before the company publishes its 2014 financial report on February 6, while anonymous sources indicated that Teva will announce its selection on January 13. 

 If selected, Vigodman, the current chief executive of agrochemical firm Makhteshim Agan Industries, will replace former CEO Jeremy Levin, who left the drugmaker in October 2013. Levin departed over reported disagreements with chairman Philip Frost concerning the implementation of the company's recent decision to cut 5000 jobs. (Más)

Ver también:
Teva Pharm to name Erez Vigodman as CEO this month/Reuters
Publicar un comentario en la entrada